Address
Merlin Nexus
230 Park Avenue
Suite 928
New York, NY 10169
United States
Phone
Website
Recent investment activity
KANDO id: 3162
Corporate information
Registration country
Funding rounds
Actual initial investment stage
N/A (1)
Investment activity status
Active investor
Selected investments
Displaying 1 - 11 of 11| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
| |
Auxilium Pharmaceuticals Inc | N/A | ||||
| |
Calypso Medical Technologies Inc | A medical device company developing innovative tools and therapies for the oncology marketa advancing cancer radiation treatment. | N/A | |||
| |
ILEX Oncology Inc | N/A | ||||
| |
Nabi Biopharmaceuticals | N/A | ||||
| |
Pharmion Corp | Initially, Pharmion concentrated its efforts on licensing products in the areas of hematology, oncology and supportive care. | N/A | |||
| |
Rigel Pharmaceuticals Inc | N/A | ||||
| |
Sunesis Pharmaceuticals Inc | Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and he | N/A | |||
| |
ARYx Therapeutics Inc | N/A | ||||
| |
Avalon Pharmaceuticals Inc | Biopharmaceutical company focused on the discovery and development of small molecule therapeutics for the treatment of cancer. | N/A | |||
| |
AVEO Pharmaceuticals Inc | Biopharmaceutical company discovering, developing and commercializing cancer therapeutics. | N/A Initial investment | |||
| |
Cougar Biotechnology Inc | N/A |